Leading the way in pharmaceutical excellence: Dubai Health Authority initiatives and services
The Dubai Health Authority took center stage at the Dubai International Pharmacy and Technology Conference and Exhibition (DUPHAT 2024), showcasing its comprehensive system for managing pharmaceutical services in the emirate. From licensing pharmacies and monitoring medicines to ensuring the safety and accessibility of medicines, the DHA is committed to promoting a strong and sustainable pharmaceutical infrastructure.
Focus on excellence:
• Licensing and inspection of pharmacies: The Dubai Health Authority ensures high standards through rigorous licensing and inspection processes for the emirate’s 1,473 pharmacies.
You can also learn more about the subject of pharmaceutical licensing from here
• Drug control: Effective policies and procedures govern the transfer, disposal and procurement of drugs in emergency situations.
• Medication safety and accessibility: Dr. Marwan Al Mulla, CEO of the Health Regulation Sector at the Dubai Health Authority, emphasizes the Authority’s focus on reviewing policies and procedures to ensure the safety of medication and quick access to it for patients.
Adopting innovation for the benefit of the patient:
• “Sheryan” system: The “Drug Delivery Licenses” service on the “Sheryan” platform facilitates the process of delivering medicines and pharmaceutical products that do not require a prescription.
• E-pharmacy services: 120 medical facilities provide e-pharmacy services, expanding access and convenience for patients searching for medical medications.
• National Unified Platform for Drug Control: This electronic system of the Ministry of Interior ensures responsible control of controlled and semi-controlled drugs and narcotics.
Setting the standard for best practices:
• Pharmacy Guidelines: DHA supports quality and safety by reviewing and issuing regulations such as the “Pharmacy Guidelines” for healthcare providers.
• Best practices in immunization guidelines: Inspired by WHO and CDC recommendations, these guidelines ensure effective immunization management and high coverage rates.
• Emergency Drugs Policy: Effective and timely care is prioritized through updates to emergency drug procurement processes and required lists for various healthcare facilities.
Conclusion:
Through its multi-faceted efforts at DUPHAT 2024, the DHA has affirmed its commitment to excellence in the pharmaceutical sector. By embracing innovation, setting high standards, and implementing best practices, DHA is paving the way for a future where quality, safety and accessibility prevail in Dubai’s pharmaceutical landscape.
You can view the various services we provide that are compatible with the perspective of the global DUPHAT event here
